Fundamental dimension Equity attribute | SCCOLeader $184.73▲+0.62% Cap $156.0BP/E 24.2x QuantScore53/100 | ANFGFPeer $41.81▲+3.23% Cap $41.22BP/E 24.3x QuantScore47/100 | BHPPeer $77.85▲+0.35% Cap $197.9BP/E 20.0x QuantScore48/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
26/100 |
18/100 |
32/100 |
Valuation Multiples, PEG & DCF upside | 66/100 | 69/100 | 66/100 |
Health Piotroski, Altman Z, leverage & liquidity | 88/100 | 75/100 | 74/100 |
Growth Revenue / earnings growth & margins | 66/100 | 72/100 | 37/100 |
Sentiment Analyst ratings, targets & revisions | 18/100 | 0/100 | 32/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 24.2x | 24.3x | 20.0x |
Forward P/E (next FY) | 23.4x | 20.5x | 15.8x |
EV / EBITDA (TTM) | 14.8x | 8.1x | 7.0x |
Price / Sales | 9.1x | 4.3x | 3.4x |
Price / Free Cash Flow | 24.1x | -430.2x | 17.0x |
PEG ratio | 0.39 | 0.24 | 2.22 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 6 / 9 | 7 / 9 |
Altman Z-Score | 10.34 (Safe) | 3.54 (Safe) | 3.63 (Safe) |
Total debt / equity | 0.63 | 0.76 | 0.53 |
Quick ratio | 3.9x | 2.2x | 1.5x |
Interest coverage | 51.4x | 25.7x | 26.6x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +17.4% | +30.3% | +14.6% |
Net income growth YoY | +28.4% | +63.8% | +9.0% |
Gross margin (TTM) | 63.8% | 53.3% | 75.6% |
Operating margin (FY) | 52.2% | 41.2% | 43.4% |
FCF margin (FY) | 25.5% | -4.5% | 20.3% |
5. Trailing price performancePrice change over period |
1M return | -8.4% | -16.8% | -8.4% |
3M return | +2.7% | -15.9% | -6.9% |
6M return | +3.8% | -17.4% | -2.5% |
Year to date | +30.5% | -5.7% | +28.9% |
1Y return | +47.1% | +18.7% | +40.8% |
3Y return | +180.3% | +168.9% | +41.9% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $77.89 -57.8% premium | $-2.66 -106.4% premium | $58.93 -24.3% premium |
Wall Street consensus target | $170.20 -7.9% · range $140.00–$193.00 | — — | $95.00 +22.0% · range $95.00–$95.00 |
Consensus stance | 10% Buy48% Hold41% Sell | 0% Buy0% Hold100% Sell | 23% Buy65% Hold13% Sell |